Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dropbox Inc (DBX) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance

Dropbox IncTrade
Edwards Lifesciences Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Dropbox Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Dropbox Inc trades at $34.15 (market cap $7.19B), while Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.9× Dropbox Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.

DBXEW
Market Cap
$7.19B$49.44B
Volume
2,804,3123,508,027
Sector
TechnologyHealth
52-Week High
$37.74$95.18
52-Week Low
$22.06$72.65
Typical Hold Time
97 Days—
Enterprise Value
$10.05B$45.90B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dropbox Inc

Dropbox (DBX) trades at $34.14, up 1.22% on the day, with a bearish technical signal and mixed analyst ratings. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $0.728. Revenue remains stable around $2.5B annually, with a high gross margin of 79.72%, but net cash flow turned negative in 2025 due to significant financing outflows. Recent news highlights insider selling and a security breach affecting 5,000 accounts.

The outlook is cautious; while profitability is solid, stagnant revenue growth and high debt levels pose risks. The consensus price target of $26.83 suggests downside potential. Investor sentiment is divided, with technical indicators signaling bearish pressure. Key risks include competitive threats and execution challenges in a mature market.

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Dropbox Inc

Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.

Read more on DBX →

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →